Paul B. Manning - 16 Dec 2024 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Paul B. Manning
Issuer symbol
CADL
Transactions as of
16 Dec 2024
Net transactions value
+$7,500,000
Form type
4
Filing time
18 Dec 2024, 16:11:47 UTC
Previous filing
26 Nov 2024
Next filing
03 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Purchase $3,000,000 +500,000 +78% $6.00 1,142,406 16 Dec 2024 By Paul B. Manning Revocable Trust F1
transaction CADL Common Stock Purchase $4,500,000 +750,000 +135% $6.00 1,303,752 16 Dec 2024 By BKB Growth Investments, LLC F2
holding CADL Common Stock 1,681,000 16 Dec 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2 The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3 Includes shares held jointly with spouse.

Remarks:

Exhibit 24 - Power of Attorney. This Power of Attorney was inadvertently omitted from the Form 4 filed on June 27, 2024.